Case report: Medical Summary – Hemostasis Evaluation

By

Patient Overview

Complex hemostatic profile with coexistence of bleeding tendency and prothrombotic factors, requiring individualized risk assessment.

1. Known / Suspected Conditions

  • Possible Von Willebrand disease type 2
    → qualitative platelet adhesion defect (bleeding tendency)
  • Possible Factor V Leiden
    → increased thrombotic risk
  • Persistent antiphospholipid antibodies
    → possible evolving Antiphospholipid syndrome

2. Key Laboratory Findings

2022 (acute phase)

  • Elevated inflammatory markers (CRP, leukocytes, LDH)
  • Coagulation abnormalities:
    • INR ↑, Quick ↓, PTT ↑
    • Reduced vitamin K–dependent factors (II, VII, IX, X)
  • Elevated D-dimer
  • Positive lupus anticoagulant

Interpretation:

  • Consistent with anticoagulation effect and acute inflammation

2023 (follow-up)

  • Lupus anticoagulant: negative
  • β2-Glycoprotein IgM: markedly elevated
  • Cardiolipin IgM: elevated

Interpretation:

  • Persistent antiphospholipid antibodies (IgM)
  • No persistent lupus anticoagulant

3. Factor VIII Status

  • Factor VIII: 126.9% (within reference range)

Interpretation:

  • Clinically stable
  • Not contributing significantly to bleeding or thrombosis
  • “Under control” reflects balanced hemostatic contribution

4. Additional Risk Factors

  • Elevated homocysteine → mild prothrombotic factor
  • Episodes of systemic inflammation → transient coagulation activation

5. Integrated Hemostatic Assessment

Bleeding risk

  • VWD type 2 (suspected)

Thrombotic risk

  • Persistent antiphospholipid antibodies
  • Possible Factor V Leiden
  • Elevated homocysteine

Overall

Mixed and dynamic hemostatic balance with competing risks

6. Neurological Risks (APS, Inflammation, and High Altitude)

A. Thrombotic and Hemorrhagic Risk at High Altitude

In patients with antiphospholipid antibodies:

  • Increased risk of:
    • Microvascular thrombosis
    • Endothelial dysfunction

At high altitude:

  • Hypoxia → increased blood viscosity
  • Hemoconcentration
  • Altered cerebral perfusion

Potential complications:

  • Cerebral venous thrombosis
  • Ischemic stroke
  • Secondary intracranial hemorrhage (less common)

Interaction with VWD:

  • May increase susceptibility to bleeding under vascular stress

B. Encephalitis

Relevance in this context

Encephalitis refers to inflammation of brain tissue, typically due to:

  • Viral infections
  • Autoimmune processes

In this patient:

  • Elevated inflammatory markers (2022) indicate systemic inflammatory activation
  • Antiphospholipid antibodies are associated with:
    • Immune dysregulation
    • Rare neurological inflammatory manifestations

Clinical considerations

  • Encephalitis is not directly caused by APS or VWD
  • However, overlapping mechanisms may contribute to:
    • Increased vulnerability during systemic illness
    • Neuroinflammatory complications in rare cases

Combined neurological risk interpretation

The patient has a predominantly thrombotic neurological risk profile (APS-related), with secondary considerations including:

  • Possible hemorrhagic complications (due to VWD and vascular stress)
  • Rare inflammatory brain involvement (encephalitis) in the context of systemic or immune activation

Clinical monitoring recommendations

  • Watch for neurological symptoms:
    • Persistent or severe headache
    • Confusion or altered consciousness
    • Seizures
    • Focal neurological deficits
    • Fever with neurological signs (suggestive of encephalitis)
  • Early medical evaluation is recommended if symptoms occur

7. Vitamin K Considerations

  • Not on anticoagulation
  • Vitamin K:
    • Safe in normal dietary intake
    • Not therapeutic for VWD or antiphospholipid antibodies
    • Supplementation not routinely indicated

8. Recommendations for Follow-up

  • Repeat antiphospholipid antibody testing
  • Clinical evaluation for thrombotic events (APS criteria)
  • Manage homocysteine (B12 / folate if indicated)
  • Periodic coagulation monitoring
  • Individualized counseling for altitude exposure and neurological risk

Summary Statement 

The patient demonstrates a complex hemostatic condition with coexisting bleeding and thrombotic tendencies. Laboratory findings show stable Factor VIII, transient lupus anticoagulant, and persistent antiphospholipid antibodies.

The patient has a complex mixed hemostatic condition with:

Confirmed
Possible VWD (bleeding tendency)

APS presents as a paradoxical hypercoagulable disorder with prolonged PTT due to lupus anticoagulant, not a true bleeding disorder.

Ongoing monitoring and individualized management are required.

There is an elevated risk of thrombotic neurological events, particularly under stress conditions such as high altitude, with secondary considerations including hemorrhagic complications and rare inflammatory processes such as encephalitis.

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a five-year copyright. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more